Pattern of soluble TNF receptors I and II in sepsis (original) (raw)
References
Vassali, P. The pathophysiology of tumor necrosis factor. Ann. Rev. Immunol. 10 (1992) 411–452. Google Scholar
Deitch, E. A. Multiple organ failure. Ann. Surg. 216 (1992) 117–134. Google Scholar
Waage, A., Halstensen, A., Espevik, T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet i (1987) 355–357. Google Scholar
Lowry, S. E. Cytokine mediators of immunity and inflammation. Arch. Surg. 128 (1993) 1235–1241. Google Scholar
Gehr, G., Gentz, R., Brockhaus, M., Loetscher, H., Lesslauer, W. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. J. Immunol. 149 (1992) 911–917. Google Scholar
Ware, C. F., Crowe, P. D., Vanarsdale, T. L., Andrews, J. L., Grayson, M. H., Jerzy, R., Smith, C. A., Goodwin, R. G. Tumor necrosis factor (TNF) receptor expression in T-lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J. Immunol. 147 (1991) 4229–4238. Google Scholar
Tartaglia, L. A., Weber, R. F., Figsri, I. S., Reynolds, C., Palladino, M. A., Goedell, D. V. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. (USA) 88 (1991) 9292–9296. Google Scholar
Tsujimoto, M., Vilcek, J. Tumor necrosis factor receptors in HeLa cells and their regulation by interferon gamma. J. Biol. Chem. 261 (1986) 5384–5388. Google Scholar
Kohno, T., Brewer, M. T., Baker, S. L., Schwartz, P. E., King, M. W., Hale, K. K., Squires, C. H., Thompson, R. C., Vannice, J. L. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proc. Natl. Acad. Sci. (USA) 87 (1990) 8331–8335. Google Scholar
Loetscher, H., Pan, Y.-C. E., Lahm, H. W., Gentz, R., Brockhaus, M., Tabuchi, H., Lesslauer, W. Molecular cloning and expression of the human 55 kD tumor necrosis factor receptor. Cell 61 (1990) 351–359. Google Scholar
Smith, C. A., Davies, T., Anderson, D., Solam, L., Beckmann, M. P., Jerzy, R., Dower, S. K., Cosman, D., Goodwin, R. G. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248 (1990) 1019–1023. Google Scholar
Froon, A. H., Bemelmanns, M. H., Greve, J. W., van der Linden, C. J., Buurman, W. A. Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome: correlation with plasma creatinine values. Crit. Care Med. 22 (1994) 803–809. Google Scholar
Rogy, M. A., Coyle, S. M., Oldenburg, H. S. A., Rock, C. S., Barie, P. S., Van Zee, K. J., Smith, C. G., Moldawer, L. L., Lowry, S. F. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients. J. Am. Coll. Surg. 178 (1994) 132–138. Google Scholar
Girardin, E., Roux-Lombard, P., Grau, G. E., Suter, P., Gallati, H., Dayer, J.-M. Imbalance between tumor necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. Immunology 76 (1992) 20–23. Google Scholar
Van Zee, K. J., Kohno, T., Fischer, E., Rock, C. S., Moldawer, L. L., Lowry, S. F. TNF soluble receptors protect against excessive TNF alpha during infection and injury. Proc. Natl. Acad. Sci. (USA) 89 (1992) 4845–4849. Google Scholar
Adolf, G. R., Fruhbeis, B. Monoclonal antibodies to soluble human TNF receptor (TNF binding protein) enhance its ability to block TNF toxicity. Cytokine 4 (1992) 180–184. Google Scholar
Bone, R. C., Sprung, C. L., Sibbald, W. J. Definitions for sepsis and organ failure. Crit. Care Med. 20 (1992) 724–726. Google Scholar
Elebute, E. A., Stoner, H. B. The grading of sepsis. Br. J. Surg. 70 (1983) 29–31. Google Scholar
Zabel, P., Schönharting, M. M., Wolter, D. T., Schade, U. F. Oxpentifylline in endotoxaemia. Lancet 334 (1989) 1474–1477. Google Scholar
Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., Wilmore, D. W. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318 (1988) 1481–1486. Google Scholar
Tracy, K. J., Lowry, S. F., Fahey, T. J. 3rd, Albert, J. D., Fong, Y., Hesse, D., Beutler, B., Manogue, K. R., Calvano, S., Wei, H., Cerami, A., Shires, G. T. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg. Gynecol. Obstet. 164 (1987) 415–422. Google Scholar
Tracy, K. J., Fong, Y., Hesse, D., Manogue, K. R., Lee, A. T., Kuo, G., Lowry, S. F., Cerami, A. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 330 (1987) 662–664. Google Scholar
Ertel, W., Morrison, M. H., Wang, P., Zheng, F., Ayala, A., Chaudry, I. H. The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin and interleukins. Ann. Surg. 214 (1991) 141–148. Google Scholar
Tracy, K. J. Tumor necrosis factor (cachectin) in the biology of septic shock syndrome. Circ. Shock 35 (1991) 123–128. Google Scholar
Fong, Y., Moldawer, L. L., Shires, G. T., Lowry, F. The biological characteristics of cytokines and their implications in surgical injury. Surg. Gynecol. Obstet. 170 (1990) 363–378. Google Scholar
Engelberts, I., Stephens, S., Francot, G. J. M., Van der Linden, C. J., Buurman, W. A. Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 338 (1991) 515–516. Google Scholar
Nophar, Y., Kemper, O., Brakebusch, C., Engelmann, H., Zwang, R., Aderka, D., Holtmann, H., Wallach, D. Soluble forms of tumor necrosis factor receptors (TNF-R's). The cDNA for the type I TNFR cloned using amino acid data of its soluble form, encodes for both the cell surface and a soluble form of the receptor. EMBO J. 9 (1990) 3269–3278. Google Scholar
Thompson, W. A., Coyle, S., Van Zee, K., Oldenburg, H., Trousdale, R., Rogy, M., Felsen, D., Moldawer, L., Lowry, S. F. The metabolic effects of platelet-activating factor antagonism in endotoxemic man. Arch. Surg. 129 (1994) 72–79. Google Scholar
Lesslauer, W., Tabuchi, H., Gentz, R., Brockhaus, M., Schlaeger, E. J., Grau, G., Piguet, P. F., Pointaire, P., Vassalli, P., Loetscher, H. Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur. J. Immunol. 21 (1991) 2883–2886. Google Scholar
Ashkenazi, A., Marsters, S. A., Capon, D. J., Chamow, S. M., Figari, I. S., Pennica, D., Goeddel, D. V., Palladino, M. A., Smith, D. H. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc. Natl. Acad. Sci. (USA) 88 (1991) 10535–10539. Google Scholar
Wong, G. H., Tartaglia, L. A., Lee, M. S., Goeddel, D. V. Antiviral activity of tumor necrosis factor is signaled through the 55 kDa receptor, type I TNF. J. Immunol. 149 (1992) 3350–3353. Google Scholar
Pfeffer, K., Matsuyama, T., Kündig, T. M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P. S., Krönke, M., Mak, T. W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to_L. monocytogenes_ infection. Cell 73 (1993) 457–467. Google Scholar